BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Topics
»
Disease categories and therapies
» Nephrology
Nephrology
RSS
Promising results reported from phase IIa trial of UISH-001
Nov. 8, 2012
Votubia obtains European approval for TSC-associated renal angiomyolipoma
Nov. 6, 2012
Keryx Biopharmaceuticals commences phase II study of Zerenex
Nov. 5, 2012
BAX B-01 shows promise in model of proliferative nephritis
Nov. 5, 2012
European Commission approves Cialis in new indication
Oct. 31, 2012
Dosing commences in phase Ib/IIa study of KD-020
Oct. 29, 2012
Astellas Pharma launches Myrbetriq in U.S.
Oct. 23, 2012
Mirabegron recommended for European approval
Oct. 22, 2012
New data on onabotulinumtoxinA reveals benefits on patient-reported outcomes
Oct. 22, 2012
Ono Pharmaceutical designs novel E-NPP 2 inhibitors
Oct. 22, 2012
Previous
1
2
…
110
111
112
113
114
115
116
117
118
…
337
338
Next
RSS